Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrograde Colonic Enema With FMT for Childhood Constipation
NCT05035784Completed
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Nov 2020
- Primary completion
- Jan 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of fecal microbiome transplant in functional constipation (FC) (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoints: Improvement of spontaneous bowel movements (SBMs) per week at 12 weeks and Satisfaction with bowel function at 12 weeks. Started Nov 2020; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT05035784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035784.